| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2005904406AAU2005904406A0 (en) | 2005-08-15 | New World Antibodies | |
| PCT/AU2006/001166WO2007019621A1 (en) | 2005-08-15 | 2006-08-15 | Chimeric antibodies with new world primate regions |
| Publication Number | Publication Date |
|---|---|
| MX2008002161Atrue MX2008002161A (en) | 2008-04-22 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2008002161AMX2008002161A (en) | 2005-08-15 | 2006-08-15 | Chimeric antibodies with new world primate regions. |
| Country | Link |
|---|---|
| EP (1) | EP1945669A4 (en) |
| JP (1) | JP2009504686A (en) |
| KR (1) | KR20080068005A (en) |
| CN (2) | CN101287762A (en) |
| AU (1) | AU2006281981A1 (en) |
| BR (2) | BRPI0614430A2 (en) |
| CA (1) | CA2619245A1 (en) |
| MX (1) | MX2008002161A (en) |
| NO (1) | NO20080800L (en) |
| NZ (1) | NZ565904A (en) |
| RU (1) | RU2008110058A (en) |
| WO (1) | WO2007019621A1 (en) |
| ZA (2) | ZA200802247B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8647625B2 (en) | 2004-07-26 | 2014-02-11 | Biogen Idec Ma Inc. | Anti-CD154 antibodies |
| CN101400703B (en) | 2006-02-01 | 2013-05-08 | 赛法隆澳大利亚控股有限公司 | domain antibody constructs |
| LT2125894T (en)* | 2007-03-22 | 2019-03-25 | Biogen Ma Inc. | Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof |
| EP2318436A4 (en)* | 2008-08-14 | 2012-12-19 | Cephalon Australia Pty Ltd | Variant domain antibodies |
| RU2516931C2 (en)* | 2010-08-06 | 2014-05-20 | Олег Ильич Эпштейн | Method and composition for preventing hiv infection, preventing and treating hiv-caused or hiv-associated diseases, including aids |
| RU2535034C2 (en)* | 2010-08-06 | 2014-12-10 | Олег Ильич Эпштейн | Medication and method of preventing hiv infection, prevention and treatment of hiv-induced or hiv-associated diseases, including aids |
| RU2517085C2 (en)* | 2010-08-06 | 2014-05-27 | Олег Ильич Эпштейн | Complex medication and method of preventing hiv infection, prevention and treatment of hiv-induced and hiv-associated diseases, including aids |
| RU2535033C2 (en)* | 2010-08-06 | 2014-12-10 | Олег Ильич Эпштейн | Therapeutic agent and method for prevention of hiv infection and treatment of hiv-caused or hiv-associated diseases, including aids |
| RU2519862C2 (en)* | 2010-08-06 | 2014-06-20 | Олег Ильич Эпштейн | Complex medication and method of prevention and treatment of infectious viral diseases |
| RU2521392C2 (en)* | 2010-08-06 | 2014-06-27 | Олег Ильич Эпштейн | Combined drug for treating viral infections and method of treating viral infections |
| RU2505312C2 (en)* | 2010-08-06 | 2014-01-27 | Олег Ильич Эпштейн | Combined therapeutic agent for treating various types of influenza |
| RU2502521C2 (en)* | 2010-08-06 | 2013-12-27 | Олег Ильич Эпштейн | Combined drug for treating bacterial infections and method of treating bacterial infections |
| RU2577299C2 (en)* | 2011-07-04 | 2016-03-10 | Олег Ильич Эпштейн | Method for treating infectious diseases and complex medication for treatment of infectious diseases |
| RU2579262C1 (en)* | 2014-10-02 | 2016-04-10 | Мапикс Эс.Эй.Ар.Эл. | Medicinal agent for treating infectious diseases |
| CL2015002152A1 (en)* | 2015-07-31 | 2016-06-03 | Pontificia Universidad Católica De Chile | Monoclonal antibodies specific for the human syncytial respiratory virus (vrsh) antigen, produced and secreted by cellular hybridomas, useful for the detection and diagnosis of infection caused by vrsh |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69233011T2 (en)* | 1991-07-25 | 2003-11-06 | Idec Pharmaceuticals Corp., San Diego | RECOMBINANT ANTIBODIES FOR HUMAN THERAPY |
| US6569431B2 (en)* | 2000-10-17 | 2003-05-27 | The Regents Of The University Of California | Recombinant antibody fragments as autoantibody antagonists |
| US7235643B2 (en)* | 2000-11-07 | 2007-06-26 | Morphotek, Inc. | Antibodies and methods for generating genetically altered antibodies with high affinity |
| ATE328906T1 (en)* | 2002-06-28 | 2006-06-15 | Domantis Ltd | DUAL-SPECIFIC LIGANDS WITH INCREASED HALF-LIFE |
| US20070212301A1 (en)* | 2003-11-07 | 2007-09-13 | Amgen, Inc. | Monkey Immunoglobulin Sequences |
| Publication number | Publication date |
|---|---|
| WO2007019621A1 (en) | 2007-02-22 |
| BRPI0614430A2 (en) | 2011-03-29 |
| CN101287763A (en) | 2008-10-15 |
| CN101287762A (en) | 2008-10-15 |
| EP1945669A4 (en) | 2009-07-22 |
| AU2006281981A1 (en) | 2007-02-22 |
| ZA200802247B (en) | 2009-08-26 |
| JP2009504686A (en) | 2009-02-05 |
| EP1945669A1 (en) | 2008-07-23 |
| BRPI0614867A2 (en) | 2012-01-31 |
| KR20080068005A (en) | 2008-07-22 |
| CA2619245A1 (en) | 2007-02-22 |
| NO20080800L (en) | 2008-05-09 |
| ZA200802246B (en) | 2009-09-30 |
| NZ565904A (en) | 2012-02-24 |
| RU2008110058A (en) | 2009-09-27 |
| Publication | Publication Date | Title |
|---|---|---|
| MX2008002161A (en) | Chimeric antibodies with new world primate regions. | |
| WO2007019620A8 (en) | Engineered antibodies with new world primate framework regions | |
| IL212949A0 (en) | Humanized anti-cd4 antibody capable of activating cd4+ cd25+ regulatory t celle | |
| WO2007129895A3 (en) | Deimmunized antagonistic anti-human cd40 monoclonal antibody from the ch5d12 antibody | |
| ATE452147T1 (en) | ANTIBODIES WITH CORRECTED CDR | |
| NZ602294A (en) | Monoclonal antibodies against c-met | |
| IL191217A (en) | Humanized monoclonal anti-il-17 antibodies | |
| NZ611269A (en) | Neutralizing anti-ccl20 antibodies | |
| WO2006031653A3 (en) | Humanized anti-5t4 antibodies and anti-5t4 antibody / calicheamicin conjugates | |
| WO2007008943A3 (en) | Optimized anti-ep-cam antibodies | |
| WO2008048970A8 (en) | Synthetic antibodies | |
| WO2007120334A3 (en) | Methods and compositions for targeting polyubiquitin | |
| PL2138512T3 (en) | Humanized anti-NGF antibodies | |
| RS53120B (en) | Antagonistic human light-specific human monoclonal antibodies | |
| EP2233501A4 (en) | Humanized anti-cd34 monoclonal antibody, the preparation and uses thereof | |
| WO2006039258A3 (en) | Human antibodies against parathyroid hormone | |
| WO2008110914A3 (en) | Methods for producing active scfv antibodies and libraries therefor | |
| WO2007149932A3 (en) | Methods and compositions for targeting hepsin | |
| WO2008052108A3 (en) | Methods for use in human-adapting monoclonal antibodies | |
| WO2007002525A3 (en) | Tomoregulin antibodies and uses thereof | |
| UA98100C2 (en) | Humanized monoclonal antibody that binds and neutralizes human nogo | |
| WO2007002096A3 (en) | Methods and compositions for targeting ifnar2 | |
| WO2007072022A3 (en) | Composition comprising an antigen-recognizing molecule and a lipid-based carrier | |
| TW200742745A (en) | Monoclonal antibody specific to enrofloxacin, hybridoma producing same and kit comprising same | |
| AU2004902842A0 (en) | Monoclonal antibody against ABCA1 |
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of company name or juridical status | ||
| FA | Abandonment or withdrawal |